Creating a Pathway to Identify and Treat Influenza in Pediatric Patients

Program Overview

The use of influenza testing and antivirals in children with influenza, especially for those considered to be high risk for complications, can greatly improve outcomes for patients with pediatric influenza. This 30-minute interactive panel discussion with infectious disease experts and a patient/parent will focus on symptom recognition, potential safety issues that may occur, and practical mechanisms for implementing optimal management practices in patients with pediatric influenza.

Credit Expired
0.5 CE Credit(s)
Expires: December 1, 2023

Target Audience

Pediatricians, family practice, and primary care clinicians managing pediatric patients with influenza.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Identify influenza in young children who are all at high risk for complications
  • Differentiate between antiviral therapies for influenza prevention and treatment in young children according to their efficacy and safety
  • Personalize antiviral therapy for influenza prevention and treatment in pediatric patients

Activity Faculty

Charles P. Vega, MD, FAAFP

Charles P. Vega, MD, FAAFP

Assistant Dean, Culture and Community Education
School of Medicine
University of California – Irvine
Irvine, CA

Ravi R. Jhaveri, MD, FIDSA, FPIDS, FAAP

Ravi R. Jhaveri, MD, FIDSA, FPIDS, FAAP

Division Head, Pediatric Infectious Diseases
Ann & Robert H. Lurie Children’s Hospital of Chicago
Professor, Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, IL

Claudette Poole, MD, MSPH

Claudette Poole, MD, MSPH

Assistant Professor
Associate Program Director, Pediatric Infectious Diseases Fellowship Program
University of Alabama at Birmingham
Birmingham, AL

Considering Therapies for Influenza Treatment and Post-Exposure in Children

Supporter Statement

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Provider Statement

Provided by RMEI Medical Education, LLC

Disclosure of Financial Relationships


Planners and Managers

Disclosure of Financial Relationships 

RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. 


Ravi R. Jhaveri, MD, FIDSA, FPIDS, FAAP, has relevant financial relationships with AstraZeneca, Dynavax Technologies, Seqirus (Consultant).

Claudette Poole, MD, MSPH, has no relevant financial relationship(s) with ineligible companies to disclose.

Charles P. Vega, MD, FAAFP, has relevant financial relationships with GlaxoSmithKline, Johnson and Johnson (Consultant).

Caregiver participating in this activity has no relevant financial relationship(s) with ineligible companies to disclose.

All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies. 

Planners and Managers

RMEI Medical Education, LLC planners and managers have no relevant financial relationship(s) with ineligible companies to disclose.

Joint Accreditation Statement 

In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credit Designation

Physician Continuing Medical Education 
RMEI Medical Education, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education 
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hour(s).

Method of Participation

To receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. You must score 75% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at [email protected]. 

Users must: 

  • Read the learning objectives and faculty disclosures 
  • Participate in the activity 
  • Complete the activity evaluation

There is no fee to participate. 



*The expense for this gift card is solely funded by RMEI Medical Education, LLC. 
No supporter funding was used for the expense of this gift card. 

Rules and Regulations 
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a jointly accredited provider. The winner will be selected via automated random drawing on a quarterly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation form and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.   

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | | (866) 770-RMEI


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources